Oxford Gene Technology Grants Microarray Licence to Febit
News Sep 21, 2005
Oxford Gene Technology (OGT) has announced that it has granted a microarray licence to febit biotech gmbh.
Dr Mike Evans, Chief Executive of OGT, said, “We are happy to support febit biotech’s technology by granting this licence and thus further the use of microarray technology”.
Peer Stähler, CSO of febit biotech gmbh said, “The agreement with OGT strengthens our IP and places us in a position to successfully market Geniom® worldwide”.
The acquired licence refers to the “Southern array patents”, fundamental patents covering the manufacture and use of DNA microarrays, and will remain valid for the patents’ lifetime.
New Inherited Neurodevelopmental Disease DiscoveredNews
Researchers have identified a new inherited neurodevelopmental disease that causes slow growth, seizures and learning difficulties in humans.READ MORE
Bird and Turtle Chromosomes Help Identify Dinosaur DNANews
Researchers have used bird and turtle DNA to extrapolate the chromosome structure of their common ancestor that lived around 260 million years ago – 20 million years before the dinosaurs first emerged. They were then able to trace the evolution of avian and non-avian dinosaur DNA through to the present day.
Over 130 Glaucoma Gene Variants Could Help Predict BlindnessNews
An international study has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness. The findings are an advance in the fight to tackle the incurable, degenerative condition, which has virtually no symptoms in the early stages, and could lead to a genetic-based screening program.READ MORE